期刊文献+

加载HPV6E7抗原肽的HLA-A2单体及其四聚体的制备和鉴定 被引量:1

Preparation and Identification of The Soluble HLA-A2 Monomer and Tetramer Loaded with HPV6E7 Antigenic Peptide
下载PDF
导出
摘要 目的制备可生物素化的可溶性HLA-A2/HPV6E7单体,进一步组装成PE标记的可溶性HLA-A2/HPV6E7四聚体。方法以原核表达的sHLA-A2BSP为重链,β2m为轻链,与人工合成的HPV6E7(22-30)抗原肽(GLH-CYEQLV)利用稀释法进行共折叠复性得到单体。利用HLAI类分子单抗(W6/3)和抗Bzm抗体进行Westernblot和ELISA鉴定折叠产物的构象。以BirA酶对其进行生物素化,经过超滤离心后得到纯化的sHLA-A2/HPV6E7单体,再与Streptavidin-PE按4:1比例混合形成四聚体。结果该四聚体具有与HLA-A2阳性HPV6感染的CA患者的抗原特异性CTL结合活性。结论成功获得了天然构象的sHLA-A2/HPV6E7单体及PE标记的HLA-A2/HPV6E7四聚体。 Objective To acquire the soluble HLA-A2 monomer loaded HPV6E7 peptide and tetramer labeled by Streptavidin-PE. Methods The heavy chain of soluble HLA-A2 and β2m were expressed highly as insoluble aggregates in E. coli, and then the two subunits were refolded to form a sHLA-A0201-monomer by dilution method in the presence of Human Papillomavirus E7 peptide(GLHCYEQLV). The refolded product was detected by ELISA and Western blot, Refolded A2-GLH monomer was biotinylated with a commercial BirA. The tetramer was then formed by mixing A2-GLH monomer with Streptavidin-PE in a ratio of 4 : 1. Results Flow cytometry analysis indicated that this tetramer could bind to specific CTL from HLA-A2 + Condyloma Acuminata (CA), Conclusion The HLA-A2/HPV6E7 monomer and tetramer loaded HPV6E7 were successfully gained.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2006年第9期519-522,共4页 The Chinese Journal of Dermatovenereology
基金 国家自然科学基金资助项目(编号:30271201) 科技部973计划课题资助项目(编号:2001CB510008)
关键词 HLA-A2 sHLA-A2/HPV6E7四聚体 尖锐湿疣 细胞毒性T细胞 HLA-A2 sHLA-A2/HPV6E7 Tetramer Condyloma Acuminate CTL
  • 相关文献

参考文献9

  • 1洪少林,王家璧,刘跃华,司静懿,许雪梅,郭秀婵,曾毅.北京地区尖锐湿疣患者皮损中人乳头瘤病毒的检测和分型[J].中国医学科学院学报,2002,24(4):397-400. 被引量:17
  • 2Altman J,Moss PAH,Goulder D,et al.Phenotypic analysis of antigenspecific T lymphocytes[J].Science,1996,274 (5284):94-96.
  • 3陈浩,翁秀芳,吴雄文,梁智辉,韩军艳,黄亚非,龚非力.人β_2m基因的克隆及表达[J].华中科技大学学报(医学版),2004,33(1):1-4. 被引量:7
  • 4Tarpey I,Stacey S,Hickling J,et al.Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7recognize a peptide containing a HLA-A2 (A * 0201) motif[J].Immunology,1994,81 (2):222 -227.
  • 5Parker KC,Bednarek MA,Coligan JE.Scheme for ranking potential HLA-A2 binging peptides based on independent binding of individual peptide side-chains.[DB/ol].http://www-bimas.cit.nih.gov/molbio/hla_bind.2005.2-12
  • 6Wang W,Man S,Gulden PH,et al.Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides[J].J Immunol,1998,160 (3):1091-1097.
  • 7Maziarz RT,Fraser J,Strominger JL,et al.The human HLA-specific monoclonal antibody W6/32 recognizes a discontinuous epitope within the alpha 2 domain of murine H-2Db[J].Immunogenetics,1986,24(3):206-208.
  • 8Rener M,Claesson MH,Bregenholt S,et al.An improved method for detection of peptide-induced upregulation of HLA-A2 molecules on TAPdeficient T2 cell[J].Exp Clin Immunogenetics,1996,13(1):30 -35.
  • 9Youde SJ,Dunbar PRR,Evans EML,et al.Use of Fluorogenic Histocompatibility Leukocyte Antigen-A * 0201/HPV 16 E7 Peptide Complexes to Isolate Rare Human Cytotoxic T-Lymphocyterecognizing Endogenous Human Papillomavirus Antigens[J].Cancer Research,2000,60 (2),365 -371.

二级参考文献8

  • 1[1]Brown DR, Schroeder JM, Fife KH, et al. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol, 1999, 37(10):3316-3322
  • 2[2]Bauer HM, Ting Y, Manos MM, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA, 1991, 265(4):472-477
  • 3[3]Bernard HU, Chan SY, Wheeler CM, et al. Identification and assessment of known and novel human papilomaviruses by PCR amplification, restriction fragment length polymorphisms, nucleotide sequence and phylogenetic algorithms. J Infect Dis, 1994, 170:1077-1085
  • 4[4]Lungu O, Wright TC, Silverstein S. Typing of human papillomaviruses by PCR amplification with L1 consensus primers and RFLP analysis. Mol Cel Probe, 1992, 6:145-152
  • 5[5]Christensen ND, Kirnbauer R, Kreider JW, et al. Human papillomavirus type 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology, 1994, 205:329-335
  • 6Garboczi D N,Hung D T,Wiley D C et al.HLA-A2-peptide complexes:refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides[].Proceedings of the National Academy of Sciences of the United States of America.1992
  • 7Bjorkman P J,Strominger J L,Wiley D C.Crystallization and X-ray diffraction studies on the histocompati-bility antigens HLA-A2 and HLA-A28 from human cell membranes[].Journal of Molecular Biology.1985
  • 8Vitiello A,Potter T A,Sherman L A.The role of beta 2-microglobulin in peptide binding by class I molecules[].Science.1990

共引文献22

同被引文献6

  • 1张彩娥,费世江,吴雄文,梁智辉,翁秀芳,陆盛军,夏芳珍,钟茂华,龚非力.同种T细胞前体频率与MHC-抗原肽种类呈正相关[J].中华微生物学和免疫学杂志,2006,26(12):1028-1031. 被引量:1
  • 2Altman JD, Moss PA, Goulder PJ, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science, 1996, 274(5284) : 94- 96.
  • 3Coleman N, Birley HD, Renton AM, et al. Immunological events in regressing genital warts. Am J Clin Pathol, 1994 , 102(6) : 768 -774.
  • 4Rener M, Claesson MH, Bregenholt S, et al. An improved method for detection of peptide-induced upregulation of HLA-A2 molecules on TAP-deficient T2 cells. Exp Clin Immunogenet, 1996, 13(1) : 30-35.
  • 5Youde SJ, Dunbar PR, Evans EM, et al. Use of fluorogenic histocompatibility leukocyte antigen-A * 0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte recognizing endogenous human papillomavirus antigens. Cancer Res, 2000, 60(2) : 365-371.
  • 6洪少林,王家璧,刘跃华,司静懿,许雪梅,郭秀婵,曾毅.北京地区尖锐湿疣患者皮损中人乳头瘤病毒的检测和分型[J].中国医学科学院学报,2002,24(4):397-400. 被引量:17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部